Breaking News

Kerry Says No Truce Accord for Gaza, Talks to Continue 
Tweet TWEET

Companies Scheduled to Present at the 32nd Annual J.P. Morgan Healthcare Conference - Research Report on InterMune, Cyberonics,

   Companies Scheduled to Present at the 32nd Annual J.P. Morgan Healthcare
Conference - Research Report on InterMune, Cyberonics, Volcano, Quintiles, and
                                   Orexigen

PR Newswire

NEW YORK, January 9, 2014

NEW YORK, January 9, 2014 /PRNewswire/ --

Editor Note: For more information about this release, please scroll to bottom.

Today, Analysts' Corner announced new research reports highlighting InterMune,
Inc. (NASDAQ: ITMN), Cyberonics, Inc. (NASDAQ: CYBX), Volcano Corporation
(NASDAQ: VOLC), Quintiles Transnational Holdings, Inc. (NYSE: Q), and Orexigen
Therapeutics, Inc. (NASDAQ: OREX). Today's readers may access these reports
free of charge - including full price targets, industry analysis and analyst
ratings - via the links below.

InterMune, Inc. Research Report

On January 6, 2014, InterMune, Inc. (InterMune) announced that it will
participate at the 32^nd Annual J.P. Morgan Healthcare Conference in San
Francisco on January 13, 2014. The Company informed that its Chairman, CEO and
President Dan Welch is scheduled to make a presentation on the aforesaid date
at 12:00 noon EST / 9:00 a.m. PST. According to the Company, investors and
other interested parties can access a live audio webcast of the presentation
via the Investors page of InterMune's corporate website. The Full Research
Report on InterMune, Inc. - including full detailed breakdown, analyst ratings
and price targets - is available to download free of charge at:

http://www.analystscorner.com/r/full_research_report/dd8c_ITMN

--

Cyberonics, Inc. Research Report

On January 6, 2014, Cyberonics, Inc. (Cyberonics) announced its participation
at the 32^nd Annual J.P. Morgan Healthcare Conference on January 15, 2014 in
San Francisco. According to the Cyberonics, Dan Moore, the Company's President
and CEO is scheduled to make the presentation on the aforesaid date at 10:00
a.m. PT. The Full Research Report on Cyberonics, Inc. - including full
detailed breakdown, analyst ratings and price targets - is available to
download free of charge at:

http://www.analystscorner.com/r/full_research_report/ad51_CYBX

--

Volcano Corporation Research Report

On January 6, 2014, Volcano Corporation (Volcano) announced its participation
at the 32^nd Annual J.P. Morgan Healthcare Conference on January 15, 2014. The
Company stated that its President and CEO Scott Huennekens is scheduled to
make the presentation on January 15, 2014, beginning 3:30 p.m. PST / 6:30 p.m.
EST. According to the Company, interested parties can access the presentation
via a link given in the website of Volcano. The Full Research Report on
Volcano Corporation - including full detailed breakdown, analyst ratings and
price targets - is available to download free of charge at:

http://www.analystscorner.com/r/full_research_report/14bf_VOLC

--

Quintiles Transnational Holdings, Inc. Research Report

On January 6, 2014, Quintiles Transnational Holdings, Inc. (Quintiles)
announced that its CEO Tom Pike will represent the Company at the 2014 J.P.
Morgan Healthcare Conference on January 15, 2014 in San Francisco at the
Westin St. Francis Hotel. The Company informed that its presentation on the
aforesaid date is scheduled to begin at 9:00 a.m. PT, and a live webcast of
the same will be available at Quintiles' website. The Full Research Report on
Quintiles Transnational Holdings, Inc. - including full detailed breakdown,
analyst ratings and price targets - is available to download free of charge
at:

http://www.analystscorner.com/r/full_research_report/9f5c_Q

--

Orexigen Therapeutics, Inc. Research Report

On January 6, 2014, Orexigen Therapeutics, Inc. (Orexigen) announced that its
management team will participate at the J.P. Morgan 2014 Healthcare Conference
in San Francisco. According to the Company, the presentation of Orexigen's
corporate overview is scheduled for January 14, 2014 at 11:30 a.m. PT. The
Company informed that a live webcast as well as a replay of the presentation
can be accessed via the Investor Relations section of Orexigen's website. The
Full Research Report on Orexigen Therapeutics, Inc. - including full detailed
breakdown, analyst ratings and price targets - is available to download free
of charge at:

http://www.analystscorner.com/r/full_research_report/1b1a_OREX

----

EDITOR NOTES:

1.This is not company news. We are an independent source and our views do
    not reflect the companies mentioned.
2.Information in this release is fact checked and produced on a best efforts
    basis and reviewed by Nidhi Vatsal, a CFA charterholder. However, we are
    only human and are prone to make mistakes. If you notice any errors or
    omissions, please notify us below.
3.This information is submitted as a net-positive to companies mentioned, to
    increase awareness for mentioned companies to our subscriber base and the
    investing public.
4.If you wish to have your company covered in more detail by our team, or
    wish to learn more about our services, please contact us at
    pubco@EquityNewsNetwork.com.
5.For any urgent concerns or inquiries, please contact us at
    compliance@EquityNewsNetwork.com.
6.Are you a public company? Would you like to see similar coverage on your
    company? Send us a full investors' package to
    research@EquityNewsNetwork.com for consideration.

COMPLIANCE PROCEDURE

Content is researched, written and reviewed on a best-effort basis. This
document, article or report is prepared and authored by Equity News Network.
An outsourced research services provider represented by Nidhi Vatsal, CFA, has
only reviewed the information provided by Equity News Network in this article
or report according to the Procedures outlined by Equity News Network. Equity
News Network is not entitled to veto or interfere in the application of such
procedures by the outsourced provider to the articles, documents or reports,
as the case may be.

NOT FINANCIAL ADVICE

Equity News Network makes no warranty, expressed or implied, as to the
accuracy or completeness or fitness for a purpose (investment or otherwise),
of the information provided in this document. This information is not to be
construed as personal financial advice. Readers are encouraged to consult
their personal financial advisor before making any decisions to buy, sell or
hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED

Equity News Network is not responsible for any error which may be occasioned
at the time of printing of this document or any error, mistake or shortcoming.
No liability is accepted by Equity News Network whatsoever for any direct,
indirect or consequential loss arising from the use of this document. Equity
News Network expressly disclaims any fiduciary responsibility or liability for
any consequences, financial or otherwise arising from any reliance placed on
the information in this document. Equity News Network does not (1) guarantee
the accuracy, timeliness, completeness or correct sequencing of the
information, or (2) warrant any results from use of the information. The
included information is subject to change without notice.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA
Institute.

SOURCE Analysts' Corner

Contact: Joe Thomas CONTACT PHONE: +1-310-496-8071 (North America)